Bioventus Inc is a medical technology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BVS is expected to report earnings to rise 36.13% to 20 cents per share on March 17
Q4'25
Est.
$0.20
Q3'25
Beat
by $0.04
Q2'25
Est.
$0.21
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.07
The last earnings report on November 04 showed earnings per share of 15 cents, beating the estimate of 10 cents. With 129.88K shares outstanding, the current market capitalization sits at 513.04M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BVS showed earnings on November 04, 2025. You can read more about the earnings report here.